Efficacy and Safety of Chiauranib in Advanced Hepatocellular Carcinoma: a Single-arm, Open-label, Multi-center, Exploratory Phase Ib Study
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2019
At a glance
- Drugs Chiauranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Chipscreen Biosciences
- 29 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 Jan 2019 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.
- 31 Aug 2018 Biomarkers information updated